Clinical Efficacy and Safety of Autologous Cultured Keratinocyte Cell on Severe Burn Wood

NCT00978705 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

19

Enrollment

INDUSTRY

Sponsor class

Conditions

Burn Wound

Interventions

DRUG: Autologous cultured keratinocyte cell

Sponsor

Biosolution Co., Ltd.